Eric Sievers Bio Atla, Inc. (BCAB) insider trading activity

Eric Sievers is Chief Medical Officer of BioAtla, Inc.. Currently has a direct ownership of 367,303 shares of BCAB, which is worth approximately $135,902. The most recent transaction as insider was on Nov 30, 2022, when has been sold 555 shares (Common Stock) at a price of $11.01 per share, resulting in proceeds of $6,110. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 367K

0.74% 3M change

76.47% 12M change

Total Value Held $135,902

Eric Sievers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 30 2022	SELL Payment of exercise price or tax liability	$6,110 $11.01 p/Share	555 Reduced 0.58%	94,508 Common Stock
Oct 31 2022	SELL Payment of exercise price or tax liability	$3,817 $6.89 p/Share	554 Reduced 0.65%	85,063 Common Stock
Sep 30 2022	SELL Payment of exercise price or tax liability	$4,273 $7.7 p/Share	555 Reduced 0.64%	85,617 Common Stock
Aug 31 2022	SELL Payment of exercise price or tax liability	$4,834 $8.71 p/Share	555 Reduced 0.64%	86,172 Common Stock
Jul 31 2022	SELL Payment of exercise price or tax liability	$1,884 $3.4 p/Share	554 Reduced 0.63%	86,727 Common Stock
Jun 30 2022	SELL Payment of exercise price or tax liability	$1,582 $2.85 p/Share	555 Reduced 0.63%	87,281 Common Stock
May 31 2022	SELL Payment of exercise price or tax liability	$1,335 $2.41 p/Share	554 Reduced 0.63%	87,836 Common Stock
Apr 30 2022	SELL Payment of exercise price or tax liability	$1,931 $3.48 p/Share	555 Reduced 0.62%	88,390 Common Stock
Mar 31 2022	SELL Payment of exercise price or tax liability	$2,770 $5.0 p/Share	554 Reduced 0.62%	88,945 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$3,596 $6.48 p/Share	555 Reduced 0.62%	89,499 Common Stock
Jan 31 2022	SELL Payment of exercise price or tax liability	$6,281 $9.56 p/Share	657 Reduced 0.72%	90,054 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$15,606 $19.63 p/Share	795 Reduced 0.87%	90,711 Common Stock
Dec 02 2021	SELL Open market or private sale	$18,130 $22.11 p/Share	820 Reduced 0.89%	91,506 Common Stock
Dec 01 2021	SELL Open market or private sale	$4,019 $23.23 p/Share	173 Reduced 0.19%	92,326 Common Stock
Nov 30 2021	SELL Open market or private sale	$3,234 $24.69 p/Share	131 Reduced 0.14%	92,499 Common Stock
Nov 29 2021	SELL Open market or private sale	$2,628 $23.89 p/Share	110 Reduced 0.12%	92,630 Common Stock
Nov 24 2021	SELL Open market or private sale	$3,217 $24.94 p/Share	129 Reduced 0.14%	92,740 Common Stock
Nov 23 2021	SELL Open market or private sale	$4,707 $25.17 p/Share	187 Reduced 0.2%	92,869 Common Stock
Nov 22 2021	SELL Open market or private sale	$3,095 $26.23 p/Share	118 Reduced 0.13%	93,056 Common Stock
Oct 01 2021	SELL Open market or private sale	$17,991 $30.39 p/Share	592 Reduced 0.63%	93,174 Common Stock
Aug 26 2021	SELL Open market or private sale	$272,498 $39.59 p/Share	6,883 Reduced 6.84%	93,766 Common Stock
Jun 14 2021	BUY Other acquisition or disposition	-	23,726 Added 19.08%	100,649 Common Stock

Eric Sievers

Chief Medical Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCAB shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Atla, Inc. insider buys or sells BCAB shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioAtla, Inc.

Track Activities on BCAB

Account